10x Genomics, Inc. — Director's Dealing 2019

Sep 12, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: Hindson Benjamin J. (Director, See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class A Common Stock	$		Class B Common Stock (3000000)		Direct
Stock Option (right to buy)	$0.88	2025-10-27	Class B Common Stock (450000)		Direct
Stock Option (right to buy)	$1.07	2026-11-18	Class B Common Stock (125000)		Direct
Stock Option (right to buy)	$1.20	2027-10-18	Class B Common Stock (200000)		Direct
Stock Option (right to buy)	$5.04	2028-11-02	Class B Common Stock (175000)		Direct
Stock Option (right to buy)	$11.48	2029-05-10	Class B Common Stock (100000)		Direct

Footnotes

F1: Each share of Class A Common Stock is convertible at any time at the option of the Reporting Person into one share of Class B Common Stock and has no expiration date. Additionally, each share of Class A Common Stock will convert automatically into one share of Class B Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Seventh Amended and Restated Certificate of Incorporation. Each share of Class A Common Stock shall be reclassified into one share of Class B Common Stock and each share of Class B Common Stock shall be reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F2: All of the shares subject to the option are fully vested and exercisable as of the date hereof.

F3: Each share of Class B Common Stock shall be reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F4: One-fourth of the shares subject to the option vested on August 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F5: One forty-eighth of the shares subject to the option vested on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F6: One forty-eighth of the shares subject to the option vested on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F7: One forty-eighth of the shares subject to the option vested on May 1, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.